Crextil-CV Dry Syrup
Composition: Cefpodoxime Proxetil 50 MG + Clavulanic Acid 31.25 MG
Packing: 30 ML
Segment: Antibiotic
MRP: ₹125
Description
Cefpodoxime 200mg + Clavulanic Acid 125mg Tablets | PCD Pharma Franchise
Product Description:
[Creogenic Pharma] offers Cefpodoxime Proxetil 50 Mg + Clavulanic Acid 31.25 MG, a potent combination antibiotic for resistant bacterial infections. Manufactured in a WHO-GMP certified facility, this formulation ensures maximum efficacy and safety for patients.
Composition:
- Cefpodoxime Proxetil 50mg
- Clavulanic Acid 31.25mg
Key Features & Benefits:
- Broad-spectrum activity against gram-positive and gram-negative bacteria
- Clavulanic acid inhibits beta-lactamase, enhancing antibiotic effectiveness
- Effective in respiratory tract, urinary tract, skin, and soft tissue infections
- WHO-GMP compliant manufacturing for global quality standards
Indications:
- Community-acquired pneumonia & bronchitis
- Urinary tract infections (UTI)
- ENT infections like sinusitis, otitis media, tonsillitis
- Skin and soft tissue infections
PCD Pharma Franchise Opportunity:
Partner with us to market Cefpodoxime + Clavulanic Acid Dry Syrup under the PCD pharma franchise model. Get monopoly rights, competitive pricing, and full promotional support to grow your antibiotic portfolio.
